Company Overview
| Stock Name | Cutia-B |
|---|---|
| Stock Code | 02487 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 公司是一家專注于皮膚學的研發型生物制藥公司，致力于開發全面的解決方案，以滿足患者及消費者在廣泛皮膚病治療及護理市場中不斷變化的多樣化需求。 |
| Listing Date | 2023-06-12 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市靜安區恒豐路436號環智國際大廈20樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.cutiatx.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 21.85 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 39.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 46,505,540 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 200 | HK$ 4,370 |
| 2 lots | 400 | HK$ 8,740 |
| 3 lots | 600 | HK$ 13,110 |
| 4 lots | 800 | HK$ 17,480 |
| 5 lots | 1,000 | HK$ 21,850 |
| 6 lots | 1,200 | HK$ 26,220 |
| 7 lots | 1,400 | HK$ 30,590 |
| 8 lots | 1,600 | HK$ 34,960 |
| 9 lots | 1,800 | HK$ 39,330 |
| 10 lots | 2,000 | HK$ 43,700 |
| 15 lots | 3,000 | HK$ 65,550 |
| 20 lots | 4,000 | HK$ 87,400 |
| 25 lots | 5,000 | HK$ 109,250 |
| 30 lots | 6,000 | HK$ 131,100 |
| 35 lots | 7,000 | HK$ 152,950 |
| 40 lots | 8,000 | HK$ 174,800 |
| 45 lots | 9,000 | HK$ 196,650 |
| 50 lots | 10,000 | HK$ 218,500 |
| 100 lots | 20,000 | HK$ 437,000 |
| 150 lots | 30,000 | HK$ 655,500 |
| 250 lots | 50,000 | HK$ 1,092,500 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 5,321 lots | 1,064,200 | HK$ 23,252,770 |
Stock Connect Inclusion
| HK Market Cap | --- |
|---|
| 26Q2 Regular Review | |
| Inclusion Pathway | None |
|---|---|
| Est. Threshold | --- |
| Analysis Result | 无法确定入通路径 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 21.95 |
|---|---|
| First Day Open | HK$ 21.8 |
| First Day Change | -79.95% |
| First Day Volume | 1319600.0 |
| First Day Turnover | 28628000.0 |
Use of Proceeds
| Use of Proceeds | 1、約176.7百萬港元（即所得款項凈額的45.0%）將用于我們的核心產品CU-20401； 2、約86.4百萬港元（即所得款項凈額的22.0%）將用于撥付我們主要產品CU-40102及CU-10201的持續研發活動； 3、約70.7百萬港元（即所得款項凈額的18.0%）將用于撥付我們管線中其他候選產品的持續研發活動； 4、約39.3百萬港元（即所得款項凈額的10.0%）乃用于管線擴展的技術開發及業務開發； 5、約19.6百萬港元（即所得款項凈額的5.0%）將用作營運資金及其他一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
China International Capital Corporation Hong Kong Securities Limited CE AEN894
Overall Coordinators (5)
Joint Bookrunners (9)
China International Capital Corporation Hong Kong Securities Limited CE AEN894
德意志银行香港分行
CLSA Limited CE AAB893
Huatai Financial Holdings (Hong Kong) Limited CE AOK809
CMB International Capital Limited CE AVM940
BOCI ASIA LIMITED CE AET863
UOB KAY HIAN (HONG KONG) LIMITED CE AAW261
Futu Securities International (Hong Kong) Limited CE AZT137
VALUABLE CAPITAL LIMITED CE AUL711
Joint Lead Managers (11)
China International Capital Corporation Hong Kong Securities Limited CE AEN894
德意志银行香港分行
CLSA Limited CE AAB893
Huatai Financial Holdings (Hong Kong) Limited CE AOK809
CMB International Capital Limited CE AVM940
BOCI ASIA LIMITED CE AET863
UOB KAY HIAN (HONG KONG) LIMITED CE AAW261
Futu Securities International (Hong Kong) Limited CE AZT137
VALUABLE CAPITAL LIMITED CE AUL711
SILVERBRICKS SECURITIES COMPANY LIMITED CE BLN458
Tiger Brokers (HK) Global Limited CE BMU940
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Harvest International Premium Value (Secondary Market) Fund SPC | 156,415,410 HKD | — | 33.64% | — | 6 months | 2023-12-12 |
| 2 | So-Young Hong Kong Limited | 7,817,930 HKD | — | 1.68% | — | 6 months | 2023-12-12 |
| 3 | 无锡新鸿笛创业投资合伙企业(有限合伙) | 17,204,690 HKD | — | 3.70% | — | 6 months | 2023-12-12 |
Directors & Management
| Chairman | 陳連勇 |
|---|---|
| Company Secretary | 梁志杰 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 通和毓承實體(49.82%);YF Dermatology Limited(13.16%);SCC Growth V 2020-C, L.P.(11.28%);Fidelity(7.47%) |
|---|
